Views sought on guidelines for genetic testing of human embryos (New Zealand)
By stuff.co.nz,
Stuff (New Zealand)
| 10. 04. 2004
Public consultation begins this week on proposed guidelines covering the testing of human embryos for serious inherited genetic conditions.
The guidelines for pre-implantation genetic diagnosis (PGD) have been formulated by the National Ethics Committee on Assisted Human Reproduction (NECAHR), a statement from the Ministry of Health said today.
PGD is a procedure used to test early human embryos for serious inherited genetic conditions. It can only be used in conjunction with in-vitro fertilisation (IVF).
Public submissions will assist in preparing a final set of guidelines, which will be submitted to health minister Annette King for approval early next year.
The discussion document and proposed guidelines are being distributed to fertility clinics, district health boards, professional organisations, consumer groups, government agencies, and individuals with an interest in the subject.
As well as calling for written submissions, NECAHR is holding a series of public meetings throughout the country to hear oral submissions. These will be held in the four main centres at the end of November.
In June last year, Ms King gave approval in principle for PGD to be offered in...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...